Pathways and crossroads to colorectal cancer

Pre-Invasive Disease: Pathogenesis and Clinical Management

Volumn , Issue , 2011, Pages 369-394

  Cattaneo, Elisa ^a   Baudis, Michael ^a   Buffoli, Federico ^b   Bianco, Maria Antonia ^c   Zorzi, Fausto ^d   Marra, Giancarlo ^a  

^a UNIVERSITY OF ZURICH   (Switzerland)

^b CREMONA HOSPITAL   (Italy)

^c Hospital A Maresca of Torre del Greco   (Italy)

^d Poliambulanza Hospital   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84895157818     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1007/978-1-4419-6694-0_18     Document Type: Chapter

References (109)

1. Winawer SJ, Zauber AG, Fletcher RH et al (2006) Guidelines for colonoscopy surveillance after polypectomy: A consensus update by the US Multi-Society Task Force on Colorectal Cancer and the American Cancer Society. Gastroenterology 130:1872-1885
2. Levine JS, Ahnen DJ (2006) Clinical practice. Adenomatous polyps of the colon. N Engl J Med 355:2551-2557
3. Gupta S (2008) Colorectal polyps: the scope and management of the problem. Am J Med Sci 336:407-417
4. Young GP, Cole SR (2009) Which fecal occult blood test is best to screen for colorectal cancer? Nat Clin Pract Gastroenterol Hepatol 6(3):140-141
5. Psaty BM, Potter JD (2006) Risks and benefits of celecoxib to prevent recurrent adenomas. N Engl J Med 355:950-952
6. Schoenfeld P, Cash B, Flood A et al (2005) Colonoscopic screening of average-risk women for colorectal neoplasia. N Engl J Med 352:2061-2068
7. Neklason DW, Thorpe BL, Ferrandez A et al (2008) Colonic adenoma risk in familial colorectal cancer-A study of six extended kindreds. Am J Gastroenterol 103:2577-2584
8. Hendriks YM, de Jong AE, Morreau H et al (2006) Diagnostic approach and management of Lynch syndrome (hereditary nonpolyposis colorectal carcinoma): A guide for clinicians. CA Cancer J Clin 56:213-225
9. Vasen HF, Moslein G, Alonso A et al (2008) Guidelines for the clinical management of familial adenomatous polyposis (FAP). Gut 57:704-713
10. Ahmadi A, Polyak S, Draganov PV (2009) Colorectal cancer surveillance in inflammatory bowel disease: the search continues. World J Gastroenterol 15:61-66
11. Roncucci L, Stamp D, Medline A, Cullen JB, Bruce WR (1991) Identification and quantification of aberrant crypt foci and microadenomas in the human colon. Hum Pathol 22:287-294
12. Hurlstone DP, Karajeh M, Sanders DS, Drew SK, Cross SS (2005) Rectal aberrant crypt foci identified using high-magnification-chromoscopic colonoscopy: biomarkers for flat and depressed neoplasia. Am J Gastroenterol 100:1283-1289
13. Takayama T, Katsuki S, Takahashi Y et al (1998) Aberrant crypt foci of the colon as precursors of adenoma and cancer. N Engl J Med 339:1277-1284
14. Takayama T, Ohi M, Hayashi T et al (2001) Analysis of K-ras, APC, and beta-catenin in aberrant crypt foci in sporadic adenoma, cancer, and familial adenomatous polyposis. Gastroenterology 121:599-611
15. Kukitsu T, Takayama T, Miyanishi K et al (2008) Aberrant crypt foci as precursors of the dysplasia-carcinoma sequence in patients with ulcerative colitis. Clin Cancer Res 14:48-54
16. Schoen RE, Mutch M, Rall C et al (2008) The natural history of aberrant crypt foci. Gastrointest Endosc 67:1097-1102
17. Winawer SJ (2007) The multidisciplinary management of gastrointestinal cancer. Colorectal cancer screening. Best Pract Res Clin Gastroenterol 21:1031-1048
18. Muto T, Kamiya J, Sawada T et al (1985) Small "flat adenoma" of the large bowel with special reference to its clinicopathologic features. Dis Colon Rectum 28:847-851
19. Kudo S, Lambert R, Allen JI et al (2008) Nonpolypoid neoplastic lesions of the colorectal mucosa. Gastrointest Endosc 68:S3-47
20. Endoscopic Classification Review Group (2005) Update on the Paris classification of superficial neoplastic lesions in the digestive tract. Endoscopy 37:570-578
21. O'Brien MJ, Winawer SJ, Zauber AG et al (2004) Flat adenomas in the National Polyp Study: is there increased risk for high-grade dysplasia initially or during surveillance? Clin Gastroenterol Hepatol 2:905-911
22. Hurlstone DP, Cross SS, Adam I et al (2003) A prospective clinicopathological and endoscopic evaluation of flat and depressed colorectal lesions in the United Kingdom. Am J Gastroenterol 98:2543-2549
23. Kudo S, Rubio CA, Teixeira CR, Kashida H, Kogure E (2001) Pit pattern in colorectal neoplasia: endoscopic magnifying view. Endoscopy 33:367-373
24. Snover DC, Jass JR, Fenoglio-Preiser C, Batts KP (2005) Serrated polyps of the large intestine: A morphologic and molecular review of an evolving concept. Am J Clin Pathol 124:380-391
25. O'Brien MJ (2007) Hyperplastic and serrated polyps of the colorectum. Gastroenterol Clin North Am 36:947-968, viii
26. Jass JR, Baker K, Zlobec I et al (2006) Advanced colorectal polyps with the molecular and morphological features of serrated polyps and adenomas: concept of a 'fusion' pathway to colorectal cancer. Histopathology 49:121-131
27. Carr NJ, Mahajan H, Tan KL, Hawkins NJ, Ward RL (2009) Serrated and non-serrated polyps of the colorectum: their prevalence in an unselected case series and correlation of BRAF mutation analysis with the diagnosis of sessile serrated adenoma. J Clin Pathol 62(6):516-518
28. Spring KJ, Zhao ZZ, Karamatic R et al (2006) High prevalence of sessile serrated adenomas with BRAF mutations: A prospective study of patients undergoing colonoscopy. Gastroenterology 131:1400-1407
29. Rosenberg DW, Yang S, Pleau DC et al (2007) Mutations in BRAF and KRAS differentially distinguish serrated versus non-serrated hyperplastic aberrant crypt foci in humans. Cancer Res 67:3551-3554
30. Makinen MJ (2007) Colorectal serrated adenocarcinoma. Histopathology 50:131-150
31. O'Brien MJ, Yang S, Mack C et al (2006) Comparison of microsatellite instability, CpG island methylation phenotype, BRAF and KRAS status in serrated polyps and traditional adenomas indicates separate pathways to distinct colorectal carcinoma end points. Am J Surg Pathol 30:1491-1501
32. Oka S, Tanaka S, Hiyama T et al (2004) Clinicopathologic and endoscopic features of colorectal serrated adenoma: differences between polypoid and superficial types. Gastrointest Endosc 59:213-219
33. Clevers H (2006) Wnt/beta-catenin signaling in development and disease. Cell 127:469-480
34. Powell SM, Zilz N, Beazer-Barclay Y et al (1992) APC mutations occur early during colorectal tumorigenesis. Nature 359:235-237
35. Groden J, Thliveris A, Samowitz W et al (1991) Identification and characterization of the familial adenomatous polyposis coli gene. Cell 66:589-600
36. Su LK, Kinzler KW, Vogelstein B et al (1992) Multiple intestinal neoplasia caused by a mutation in the murine homolog of the APC gene. Science 256:668-670
37. Iwamoto M, Ahnen DJ, Franklin WA, Maltzman TH (2000) Expression of beta-catenin and fulllength APC protein in normal and neoplastic colonic tissues. Carcinogenesis 21:1935-1940
38. Barker N, Ridgway RA, van Es JH et al (2009) Crypt stem cells as the cells-of-origin of intestinal cancer. Nature 457:608-611
39. Zhu L, Gibson P, Currle DS et al (2009) Prominin 1 marks intestinal stem cells that are susceptible to neoplastic transformation. Nature 457:603-607
40. Ilyas M, Tomlinson IP, Rowan A, Pignatelli M, Bodmer WF (1997) Beta-catenin mutations in cell lines established from human colorectal cancers. Proc Natl Acad Sci U S A 94: 10330-10334
41. Morin PJ, Sparks AB, Korinek V et al (1997) Activation of beta-catenin-Tcf signaling in colon cancer by mutations in beta-catenin or APC. Science 275:1787-1790
42. Samowitz WS, Powers MD, Spirio LN et al (1999) Beta-catenin mutations are more frequent in small colorectal adenomas than in larger adenomas and invasive carcinomas. Cancer Res 59:1442-1444
43. Suzuki H, Watkins DN, Jair KW et al (2004) Epigenetic inactivation of SFRP genes allows constitutive WNT signaling in colorectal cancer. Nat Genet 36:417-422
44. Schneikert J, Grohmann A, Behrens J (2007) Truncated APC regulates the transcriptional activity of beta-catenin in a cell cycle dependent manner. Hum Mol Genet 16:199-209
45. Segditsas S, Rowan AJ, Howarth K et al (2009) APC and the three-hit hypothesis. Oncogene 28:146-155
46. Alberici P, Fodde R (2006) The role of the APC tumor suppressor in chromosomal instability. Genome Dyn 1:149-170
47. Cardoso J, Molenaar L, de Menezes RX et al (2006) Chromosomal instability in MYH-and APC-mutant adenomatous polyps. Cancer Res 66:2514-2519
48. Luo L, Li B, Pretlow TP (2003) DNA alterations in human aberrant crypt foci and colon cancers by random primed polymerase chain reaction. Cancer Res 63:6166-6169
49. Sieber OM, Heinimann K, Gorman P et al (2002) Analysis of chromosomal instability in human colorectal adenomas with two mutational hits at APC. Proc Natl Acad Sci U S A 99:16910-16915
50. Bartkova J, Rezaei N, Liontos M et al (2006) Oncogene-induced senescence is part of the tumorigenesis barrier imposed by DNA damage checkpoints. Nature 444:633-637
51. Raynaud CM, Jang SJ, Nuciforo P et al (2008) Telomere shortening is correlated with the DNA damage response and telomeric protein down-regulation in colorectal preneoplastic lesions. Ann Oncol 19:1875-1881
52. Vogelstein B, Fearon ER, Hamilton SR et al (1988) Genetic alterations during colorectal-tumor development. N Engl J Med 319:525-532
53. Grant S (2008) Cotargeting survival signaling pathways in cancer. J Clin Invest 118:3003-3006
54. Wood LD, Parsons DW, Jones S et al (2007) The genomic landscapes of human breast and colorectal cancers. Science 318:1108-1113
55. Sweeney C, Boucher KM, Samowitz WS et al (2009) Oncogenetic tree model of somatic mutations and DNA methylation in colon tumors. Genes Chromosomes Cancer 48:1-9
56. Shen L, Toyota M, Kondo Y et al (2007) Integrated genetic and epigenetic analysis identifies three different subclasses of colon cancer. Proc Natl Acad Sci U S A 104:18654-18659
57. Samowitz WS, Slattery ML, Sweeney C et al (2007) APC mutations and other genetic and epigenetic changes in colon cancer. Mol Cancer Res 5:165-170
58. Goel A, Arnold CN, Niedzwiecki D et al (2003) Characterization of sporadic colon cancer by patterns of genomic instability. Cancer Res 63:1608-1614
59. Toyota M, Ahuja N, Ohe-Toyota M et al (1999) CpG island methylator phenotype in colorectal cancer. Proc Natl Acad Sci U S A 96:8681-8686
60. O'Brien MJ, Yang S, Clebanoff JL et al (2004) Hyperplastic (serrated) polyps of the colorectum: relationship of CpG island methylator phenotype and K-ras mutation to location and histologic subtype. Am J Surg Pathol 28:423-434
61. Chan TL, Zhao W, Leung SY, Yuen ST (2003) BRAF and KRAS mutations in colorectal hyperplastic polyps and serrated adenomas. Cancer Res 63:4878-4881
62. Nosho K, Irahara N, Shima K et al (2008) Comprehensive biostatistical analysis of CpG island methylator phenotype in colorectal cancer using a large population-based sample. PLoS ONE 3:e3698
63. Kambara T, Simms LA, Whitehall VL et al (2004) BRAF mutation is associated with DNA methylation in serrated polyps and cancers of the colorectum. Gut 53:1137-1144
64. Weisenberger DJ, Siegmund KD, Campan M et al (2006) CpG island methylator phenotype underlies sporadic microsatellite instability and is tightly associated with BRAF mutation in colorectal cancer. Nat Genet 38:787-793
65. Goel A, Nagasaka T, Arnold CN et al (2007) The CpG island methylator phenotype and chromosomal instability are inversely correlated in sporadic colorectal cancer. Gastroenterology 132:127-138
66. Menigatti M, Truninger K, Gebbers JO et al (2009) Normal colorectal mucosa exhibits sexand segment-specific susceptibility to DNA methylation at the hMLH1 and MGMT promoters. Oncogene 28:899-909
67. Samowitz WS, Albertsen H, Sweeney C et al (2006) Association of smoking, CpG island methylator phenotype, and V600E BRAF mutations in colon cancer. J Natl Cancer Inst 98:1731-1738
68. Laiho P, Kokko A, Vanharanta S et al (2007) Serrated carcinomas form a subclass of colorectal cancer with distinct molecular basis. Oncogene 26:312-320
69. Lee SH, Kim J, Kim WH, Lee YM (2009) Hypoxic silencing of tumor suppressor RUNX3 by histone modification in gastric cancer cells. Oncogene 28:184-194
70. di Pietro M, Sabates Bellver J, Menigatti M et al (2005) Defective DNA mismatch repair determines a characteristic transcriptional profile in proximal colon cancers. Gastroenterology 129:1047-1059
71. Sabates-Bellver J, Van der Flier LG, de Palo M et al (2007) Transcriptome profile of human colorectal adenomas. Mol Cancer Res 5:1263-1275
72. Knudsen AL, Bisgaard ML, Bulow S (2003) Attenuated familial adenomatous polyposis (AFAP). A review of the literature. Fam Cancer 2:43-55
73. Schneikert J, Behrens J (2007) The canonical Wnt signalling pathway and its APC partner in colon cancer development. Gut 56:417-425
74. Sabates Bellver J, Cattaneo E, Heinimann K, Jiricny J, Marra G (2007) Getting familiar with familial colon cancer. In: Gasche C (ed) Intestinal inflammation and colorectal cancer (FALK Symposium 158). Springer, New York, pp 27-60
75. Al-Tassan N, Chmiel NH, Maynard J et al (2002) Inherited variants of MYH associated with somatic G:C?T:A mutations in colorectal tumors. Nat Genet 30:227-232
76. Sieber OM, Lipton L, Crabtree M et al (2003) Multiple colorectal adenomas, classic adenomatous polyposis, and germ-line mutations in MYH. N Engl J Med 348:791-799
77. Marra G, Jiricny J (2003) Multiple colorectal adenomas-is their number up? N Engl J Med 348:845-847
78. Marra G, Jiricny J (2005) DNA mismatch repair and colon cancer. In: Nigg E (ed) Genome instability in cancer development (advances in experimental medicine and biology). Springer, New York, pp 85-123
79. Truninger K, Menigatti M, Luz J et al (2005) Immunohistochemical analysis reveals high frequency of PMS2 defects in colorectal cancer. Gastroenterology 128:1160-1171
80. de Jong AE, Morreau H, Van Puijenbroek M et al (2004) The role of mismatch repair gene defects in the development of adenomas in patients with HNPCC. Gastroenterology 126:42-48
81. Markowitz S, Wang J, Myeroff L et al (1995) Inactivation of the type II TGF-beta receptor in colon cancer cells with microsatellite instability. Science 268:1336-1338
82. Rampino N, Yamamoto H, Ionov Y et al (1997) Somatic frameshift mutations in the BAX gene in colon cancers of the microsatellite mutator phenotype. Science 275:967-969
83. Burt RW, Jass JR (2000) Hyperplastic polyposis. In: Hamilton SR, Aaltonen LA (eds) World Health Organization classification of tumors. Pathology and genetics. Tumors of the digestive system. Springer, Berlin, pp 135-136
84. Jass JR (2000) Familial colorectal cancer: pathology and molecular characteristics. Lancet Oncol 1:220-226
85. Ferrandez A, Samowitz W, DiSario JA, Burt RW (2004) Phenotypic characteristics and risk of cancer development in hyperplastic polyposis: case series and literature review. Am J Gastroenterol 99:2012-2018
86. Lage P, Cravo M, Sousa R et al (2004) Management of Portuguese patients with hyperplastic polyposis and screening of at-risk first-degree relatives: A contribution for future guidelines based on a clinical study. Am J Gastroenterol 99:1779-1784
87. Torlakovic E, Snover DC (2006) Sessile serrated adenoma: A brief history and current status. Crit Rev Oncog 12:27-39
88. Jass JR (2008) Colorectal polyposes: from phenotype to diagnosis. Pathol Res Pract 204:431-447
89. Beach R, Chan AO, Wu TT et al (2005) BRAF mutations in aberrant crypt foci and hyperplastic polyposis. Am J Pathol 166:1069-1075
90. Minoo P, Baker K, Goswami R et al (2006) Extensive DNA methylation in normal colorectal mucosa in hyperplastic polyposis. Gut 55:1467-1474
91. Young J, Jass JR (2006) The case for a genetic predisposition to serrated neoplasia in the colorectum: hypothesis and review of the literature. Cancer Epidemiol Biomarkers Prev 15:1778-1784
92. Cho JH (2008) The genetics and immunopathogenesis of inflammatory bowel disease. Nat Rev Immunol 8:458-466
93. Xavier RJ, Podolsky DK (2007) Unravelling the pathogenesis of inflammatory bowel disease. Nature 448:427-434
94. Budarf ML, Labbe C, David G, Rioux JD (2009) GWA studies: rewriting the story of IBD. Trends Genet 25(3):137-146
95. Eaden JA, Abrams KR, Mayberry JF (2001) The risk of colorectal cancer in ulcerative colitis: A meta-analysis. Gut 48:526-535
96. Canavan C, Abrams KR, Mayberry J (2006) Meta-analysis: colorectal and small bowel cancer risk in patients with Crohn's disease. Aliment Pharmacol Ther 23:1097-1104
97. Itzkowitz SH, Yio X (2004) Inflammation and cancer IV. Colorectal cancer in inflammatory bowel disease: the role of inflammation. Am J Physiol Gastrointest Liver Physiol 287:G7-17
98. Itzkowitz SH, Harpaz N (2004) Diagnosis and management of dysplasia in patients with inflammatory bowel diseases. Gastroenterology 126:1634-1648
99. Kiesslich R, Goetz M, Lammersdorf K et al (2007) Chromoscopy-guided endomicroscopy increases the diagnostic yield of intraepithelial neoplasia in ulcerative colitis. Gastroenterology 132:874-882
100. Kornbluth A, Sachar DB (1997) Ulcerative colitis practice guidelines in adults. American College of Gastroenterology, Practice Parameters Committee. Am J Gastroenterol 92:204-211
101. Lewis JD (2003) The many faces of low-grade dysplasia. Gastroenterology 125:1531-1533
102. Yin J, Harpaz N, Tong Y et al (1993) p53 point mutations in dysplastic and cancerous ulcerative colitis lesions. Gastroenterology 104:1633-1639
103. Brentnall TA, Crispin DA, Rabinovitch PS et al (1994) Mutations in the p53 gene: an early marker of neoplastic progression in ulcerative colitis. Gastroenterology 107:369-378
104. Fujii S, Fujimori T, Chiba T (2003) Usefulness of analysis of p53 alteration and observation of surface microstructure for diagnosis of ulcerative colitis-associated colorectal neoplasia. J Exp Clin Cancer Res 22:107-115
105. Konishi K, Shen L, Wang S et al (2007) Rare CpG island methylator phenotype in ulcerative colitis-associated neoplasias. Gastroenterology 132:1254-1260
106. Risques RA, Rabinovitch PS, Brentnall TA (2006) Cancer surveillance in inflammatory bowel disease: new molecular approaches. Curr Opin Gastroenterol 22:382-390
107. Risques RA, Lai LA, Brentnall TA et al (2008) Ulcerative colitis is a disease of accelerated colon aging: evidence from telomere attrition and DNA damage. Gastroenterology 135:410-418
108. Willenbucher RF, Aust DE, Chang CG et al (1999) Genomic instability is an early event during the progression pathway of ulcerative-colitis-related neoplasia. Am J Pathol 154:1825-1830
109. Baudis M, Cleary ML (2001) Progenetix.net: an online repository for molecular cytogenetic aberration data. Bioinformatics 17:1228-1229